Rhythm vs Rate Control Strategy for Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials
Zurich Open Repository and Archive (University of Zurich) · 05.02.2025
DOI: 10.5167/uzh-270524 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Zurich Open Repository and Archive (University of Zurich), erschienen am 05.02.2025. Verfasst von Zafeiropoulos und 25 weiteren Autor:innen.
Abstract (Originalsprache)
BACKGROUND Rhythm control, either with antiarrhythmic drugs or catheter ablation, and rate control strategies are the cornerstones of atrial fibrillation (AF) management. Despite the increasing role of rhythm control over the past few years, it remains inconclusive which strategy is superior in improving clinical outcomes. OBJECTIVES This study summarizes the total and time-varying evidence regarding the efficacy of rhythm- vs rate-control strategies in the management of AF. METHODS We systematically perused the MEDLINE, CENTRAL (Cochrane Central Register of Controlled Trials), and Web of Science databases for randomized controlled trials from inception to November 2023. We included studies that compared the efficacy of rhythm control (ie, antiarrhythmic drugs classes Ia, Ic, or III, AF catheter ablation, and electrical cardioversion) and rate control (ie, beta-blocker, digitalis, or calcium antagonist) strategies among patients with nonvalvular AF. The primary outcome was cardiovascular (CV) death, whereas secondary outcomes included all-cause death, stroke, hospitalization for heart failure (HF), sinus rhythm at the end of the follow-up, and rhythm control-related adverse events. A cumulative meta-analysis to assess temporal trends and a meta-regression analysis using the percentage of ablation use was performed. RESULTS We identified 18 studies with a total of 17,536 patients (mean age: 68.6 ± 9.7 years, 37.9% females) and a mean follow-up of 28.5 months. Of those, 31.9% had paroxysmal AF. A rhythm control strategy reduced CV death (HR: 0.78; 95% CI: 0.62-0.96), stroke (HR: 0.801; 95% CI: 0.643-0.998), and hospitalization for HF (HR: 0.80; 95% CI: 0.69-0.94) but not all-cause death (HR: 0.86; 95% CI: 0.73-1.02) compared with a rate control strategy. This benefit was driven by contemporary studies, whereas more ablation use within the rhythm control arm was associated with improved outcomes, except stroke. CONCLUSIONS In patients with AF, a contemporary rhythm control strategy leads to reduced CV mortality, HF events, and stroke compared with a rate control strategy.
Schlagwörter
Zitieren
APA
Zafeiropoulos, Stefanos, Doundoulakis, Ioannis, Bekiaridou, Alexandra, Farmakis, T, I., Papadopoulos, E, G., Coleman, M, K., Giannakoulas, George, Zanos, Stavros, Tsiachris, Dimitris, Duru, …, & Stavros (2025). Rhythm vs Rate Control Strategy for Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials. Zurich Open Repository and Archive (University of Zurich). https://doi.org/10.5167/uzh-270524
Vancouver
Zafeiropoulos, Stefanos, Doundoulakis, Ioannis, Bekiaridou, Alexandra, et al. Rhythm vs Rate Control Strategy for Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials. Zurich Open Repository and Archive (University of Zurich). 2025. doi:10.5167/uzh-270524
BibTeX
@article{Zafeiropoulos2025,
author = {Zafeiropoulos and Stefanos and Doundoulakis and Ioannis and Bekiaridou and Alexandra and Farmakis and T, Ioannis and Papadopoulos and E, Georgios and Coleman and M, Kristie and Giannakoulas and George and Zanos and Stavros and Tsiachris and Dimitris and Duru and Firat and Saguner and Muammer, Ardan and Mountantonakis and E, Stavros and Stavrakis and Stavros},
title = {Rhythm vs Rate Control Strategy for Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials},
journal = {Zurich Open Repository and Archive (University of Zurich)},
year = {2025},
doi = {10.5167/uzh-270524}
}
EUVIMED